Collard Craig A

Chief Executive Officer

Heron Therapeutics, Inc.

US, San Diego [HQ]

CIK 1363558

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

262,793

Price per Share :

$1.52

Equivalence :

$399,445.36

M

Form 4

262,793 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 04/19/24
- Footnotes
- Form 4
Footnotes:
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
M

Form 4

248,996 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 04/03/24
- Footnotes
- Form 4
Footnotes:
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
M

Form 4

290,387 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 10/19/24
- Footnotes
- Form 4
Footnotes:
#1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F

Form 4

37,188 Shares After Transaction

Value : $53,922.60

$1,001.95

Transaction Date : 05/22/23
- Footnotes
- Form 4
Footnotes:
#1 Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to the quarterly vesting of shares from the restricted stock grant made on February 22, 2023.
P

Form 4

186,496 Shares After Transaction

Value : $171,576.32

$138,000.00

Transaction Date : 11/16/23
- Footnotes
- Form 4
Footnotes:
#1 The range of purchase prices paid was $0.8888 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.

Get PRO Today.

PRO unlocks 2 more insider transactions made by Collard Craig A

Start Free PRO trial Subscribe to PRO

NASDAQ

United States

San Diego

Healthcare